Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants

This publication has 8 references indexed in Scilit:

• Haemophilus influenzae type b polysaccharidetetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age
  The Pediatric Infectious Disease Journal, 1993
• Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis Group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheriatetanus-pertussis vaccine in young Gambian infants
  The Pediatric Infectious Disease Journal, 1993
• Universal Hepatitis B Immunization
  Pediatrics, 1992
• Safety and immunogenicity of acellular diphtheria-tetanus-pertussis and Haemophilus conjugate vaccines given in combination or at separate injection sites
  The Journal of Pediatrics, 1992
• The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age
  The Pediatric Infectious Disease Journal, 1991
• Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants
  The Pediatric Infectious Disease Journal, 1991
• Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood
  The Pediatric Infectious Disease Journal, 1988
• PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTS
  The Lancet, 1988